SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-23-115745
Filing Date
2023-11-08
Accepted
2023-11-08 16:17:54
Documents
1
Effectiveness Date
2023-11-08

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2330210d4_s8pos.htm S-8 POS 29026
  Complete submission text file 0001104659-23-115745.txt   30115
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-233248 | Film No.: 231388146
SIC: 2834 Pharmaceutical Preparations